Our Transitions: Improving the Path to Menopause With Personal Digital Health Technologies (NCT07597915) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Our Transitions: Improving the Path to Menopause With Personal Digital Health Technologies
1,250 participantsStarted 2026-05-01
Plain-language summary
The goal of this observational study is to build knowledge about the path to menopause using subjective, self-reported and objectively measured information from multiple wearable study devices and a smartphone app. This study is being done in female individuals who are 35-55 years of age. The eventual aim of this work is two-fold; 1) to increase knowledge, awareness and education for individuals and clinicians about the lived experience of perimenopause and menopause through objectively measured data from digital study devices, and 2) to develop approaches to empower female individuals to manage this transition by learning what improves or worsens their symptoms.
Who can participate
Age range
35 Years – 55 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Are 35-55 years old
* Reside in the US or Canada
* Are able to speak, write, and read English
* Are able to provide informed consent
* Have a personally owned iPhone (iOS Version 16.4)
Exclusion Criteria:
* Are not willing to wear a wearable study device
* Have a hormonal intrauterine device (IUD)
* Are taking birth control pills
* Are taking systemic estrogen or progesterone
* Have been diagnosed with Polycystic ovary syndrome (PCOS)
* Are taking the following medications (cancer treatment that affects the menstrual cycle, thyroid medication)
* Have had the following procedures (hysterectomy \[removal of uterus\], bilateral, oophorectomy \[removal of both ovaries\], endometrial ablation \[surgery that destroys the lining of the uterus\])
* Are currently pregnant, attempting to conceive, recently pregnant and not yet cycling and currently breast feeding
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility: Retention
Timeframe: From enrollment to the end of participation at 12 months
2
Feasibility: Adherence
Timeframe: From enrollment to the end of participation at 12 months